A Three-mRNA Signature Associated with Pyrimidine Metabolism for Prognosis of BRCA

Table 1

Clinical parameters of patients with BRCA from TCGA.

Clinical parameters		%	Dead number
Age (years)
≥58	581	52.44	89
<58	527	47.56	66
pTNM stage
Stage I	183	16.52	16
Stage II	626	56.50	69
Stage III	251	22.65	44
Stage IV	20	1.80	15
Unknown	28	2.53	11
Primary tumor
T1	282	25.45	33
T2	641	57.85	81
T3	138	12.45	25
T4	40	3.61	15
Unknown	7	0.63	1
Regional lymph nodes
N0	553	49.91	48
N1	332	29.96	59
N2	120	10.83	22
N3	79	7.13	15
Unknown	24	2.17	11
Metastasis
M0	918	82.85	124
M1	22	1.99	17
Unknown	168	15.16	14
Person neoplasm status
With tumor	96	8.67	88
Tumor-free	882	79.60	39
Unknown	130	11.73	15
ER status by IHC
Negative	239	21.57	42
Positive	814	73.47	102
Unknown	55	4.96	11
PR status by IHC
Negative	345	31.14	57
Positive	705	63.63	88
Unknown	58	5.23	10
HER-2 status by IHC
Negative	567	51.17	59
Positive	164	14.80	23
Unknown	377	34.03	73